×
About 255 results

ALLMedicine™ Nontuberculous Mycobacterial Lung Disease Center

Research & Reviews  125 results

Predictors of starting antimicrobial treatment in patients with nontuberculous mycobact...
https://doi.org/10.1016/j.rmed.2021.106341
Respiratory Medicine; Lombardi A, Colaneri M et. al.

Feb 22nd, 2021 - The disease burden due to nontuberculous mycobacteria is growing worldwide, consequently to improved diagnostic abilities and an increase in the individuals at risk. Uncertainties exist about the right moment on which start treatment. We investiga...

A multidisciplinary approach to the management of nontuberculous mycobacterial lung dis...
https://doi.org/10.1080/17476348.2021.1887734
Expert Review of Respiratory Medicine; Ali J

Feb 17th, 2021 - Management of nontuberculous mycobacterial lung disease (NTM-LD) can be encumbered by difficult diagnostic criteria and complex treatment decisions. As prevalence of this debilitating, often refractory, progressive lung disease increases globally,...

Population Pharmacokinetic Evaluation of Amikacin Liposome Inhalation Suspension in Pat...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935831
European Journal of Drug Metabolism and Pharmacokinetics; Rubino CM, Onufrak NJ et. al.

Feb 17th, 2021 - Use of parenteral amikacin to treat refractory nontuberculous mycobacterial (NTM) lung disease is limited by systemic toxicity. A population pharmacokinetic model was developed using data pooled from two randomized trials to evaluate the pharmacok...

Novel Assays/Applications for Patients Suspected of Mycobacterial Diseases.
https://doi.org/10.1016/j.cll.2020.08.010
Clinics in Laboratory Medicine; Banaei N, Musser KA et. al.

Oct 30th, 2020 - Although tuberculosis is slowly decreasing, nontuberculous mycobacterial lung disease is significantly increasing. We describe new methods and applications for faster turnaround times in the diagnosis of tuberculosis and nontuberculous mycobacteri...

Extensive Lung Resection for Nontuberculous Mycobacterial Lung Disease With Multilobar ...
https://doi.org/10.1016/j.athoracsur.2020.05.067
The Annals of Thoracic Surgery; Yamada K, Seki Y et. al.

Jul 5th, 2020 - Nontuberculous mycobacterial lung disease often spreads to multiple lobes, and extensive lung resection (ELR) is sometimes required to control the disease. The safety and feasibility of ELR for nontuberculous mycobacterial lung disease remain uncl...

see more →

Clinicaltrials.gov  127 results

Predictors of starting antimicrobial treatment in patients with nontuberculous mycobact...
https://doi.org/10.1016/j.rmed.2021.106341
Respiratory Medicine; Lombardi A, Colaneri M et. al.

Feb 22nd, 2021 - The disease burden due to nontuberculous mycobacteria is growing worldwide, consequently to improved diagnostic abilities and an increase in the individuals at risk. Uncertainties exist about the right moment on which start treatment. We investiga...

A multidisciplinary approach to the management of nontuberculous mycobacterial lung dis...
https://doi.org/10.1080/17476348.2021.1887734
Expert Review of Respiratory Medicine; Ali J

Feb 17th, 2021 - Management of nontuberculous mycobacterial lung disease (NTM-LD) can be encumbered by difficult diagnostic criteria and complex treatment decisions. As prevalence of this debilitating, often refractory, progressive lung disease increases globally,...

Population Pharmacokinetic Evaluation of Amikacin Liposome Inhalation Suspension in Pat...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935831
European Journal of Drug Metabolism and Pharmacokinetics; Rubino CM, Onufrak NJ et. al.

Feb 17th, 2021 - Use of parenteral amikacin to treat refractory nontuberculous mycobacterial (NTM) lung disease is limited by systemic toxicity. A population pharmacokinetic model was developed using data pooled from two randomized trials to evaluate the pharmacok...

Novel Assays/Applications for Patients Suspected of Mycobacterial Diseases.
https://doi.org/10.1016/j.cll.2020.08.010
Clinics in Laboratory Medicine; Banaei N, Musser KA et. al.

Oct 30th, 2020 - Although tuberculosis is slowly decreasing, nontuberculous mycobacterial lung disease is significantly increasing. We describe new methods and applications for faster turnaround times in the diagnosis of tuberculosis and nontuberculous mycobacteri...

Extensive Lung Resection for Nontuberculous Mycobacterial Lung Disease With Multilobar ...
https://doi.org/10.1016/j.athoracsur.2020.05.067
The Annals of Thoracic Surgery; Yamada K, Seki Y et. al.

Jul 5th, 2020 - Nontuberculous mycobacterial lung disease often spreads to multiple lobes, and extensive lung resection (ELR) is sometimes required to control the disease. The safety and feasibility of ELR for nontuberculous mycobacterial lung disease remain uncl...

see more →

News  3 results

Nontuberculous mycobacterial lung disease cases on the rise across U.S.
https://www.mdedge.com/fedprac/article/215787/infectious-diseases/nontuberculous-mycobacterial-lung-disease-cases-rise?channel=234
Steve Cimino

Jan 21st, 2020 - A new study of claims-based data has found that the incidence and prevalence of nontuberculous mycobacterial (NTM) lung disease is increasing in most states. Dr.

Anticipate Mycobacterial Lung Disease in Anti-TNF Users
https://www.mdedge.com/dermatology/article/47474/psoriasis/anticipate-mycobacterial-lung-disease-anti-tnf-users/page/0/1

Feb 14th, 2012 - Dr. Winthrop said he is reluctant to recommend resuming biologic therapy after a RA patient has been treated for nontuberculous mycobacterial lung disease or coccidioidomycosis.

see more →